ArticleDiabetology international2016

Baseline low-density lipoprotein cholesterol predicts the hemoglobin A1c-lowering effect of dapagliflozin in Japanese patients with type 2 diabetes mellitus.

Tomoyuki Iwasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.